ACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance
| Autor: | J. S. Weese, Jane E. Sykes, Luca Guardabassi, Daniel R. Ricciuto, Mark G. Papich, Paul S. Morley, S. Giguère |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Societies
Scientific Veterinary Medicine medicine.medical_specialty medicine.drug_class ACVIM Consensus Statement Antibiotics Drug Resistance Human pathogen Therapeutics Health benefits Antimicrobial stewardship Vaccine Related Antibiotic resistance Biodefense Drug Resistance Bacterial medicine Animals Veterinary Sciences Animal Husbandry Intensive care medicine Adverse effect Public health General Veterinary Bacteria business.industry Prevention Bacterial Veterinary Drugs Scientific Bacterial Infections Antimicrobial United States Biotechnology Anti-Bacterial Agents Antimicrobial use Emerging Infectious Diseases Infectious Diseases Good Health and Well Being Zero Hunger Antimicrobial Resistance business Societies Infection |
| Zdroj: | Journal of veterinary internal medicine, vol 29, iss 2 Journal of Veterinary Internal Medicine |
| Popis: | The epidemic of antimicrobial resistant infections continues to challenge, compromising animal care, complicating food animal production and posing zoonotic disease risks. While the overall role of therapeutic antimicrobial use in animals in the development AMR in animal and human pathogens is poorly defined, veterinarians must consider the impacts of antimicrobial use in animal and take steps to optimize antimicrobial use, so as to maximize the health benefits to animals while minimizing the likelihood of antimicrobial resistance and other adverse effects. This consensus statement aims to provide guidance on the therapeutic use of antimicrobials in animals, balancing the need for effective therapy with minimizing development of antimicrobial resistance in bacteria from animals and humans. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|